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Stat5a and Stat5b Proteins Have Essential
and Nonessential, or Redundant, Roles
in Cytokine Responses
innate and acquired immunity. Stat1 is critical for inter-
feron (IFN)±induced viral resistance (Durbin et al., 1996;
Meraz et al., 1996). Similarly, Stat6 specifically mediates
the effects of IL-4 or IL-13 on B or T cells (Kaplan et al.,
1996a; Shimoda et al., 1996), while Stat4 is critical for
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IL-12 signaling (Kaplan et al., 1996b; Thierfelder et al.,1Howard Hughes Medical Institute
1996). The one possible exception is Stat3, which, when2Department of Biochemistry
deleted, results in a very early embryonic lethality due3Department of Genetics
to unknown deficiencies (Takeda et al., 1997).4Department of Pharmaceutical Sciences
Stat5 was identified as a prolactin-induced mammary5Department of Pathology
gland transcription factor (Wakao et al., 1994). It was6Department of Hematology Oncology
shown that two Stat5 genes encode proteins that areSt. Jude Children's Research Hospital
approximately 95% identical in amino acid sequenceMemphis, Tennessee 38105
(Liu et al., 1995) and that these two genes colocalized7Department of Biochemistry
to murine chromosome 11, tightly linked to Stat3 (Cope-University of Tennessee Medical School, Memphis
land et al., 1995). The identity and chromosomal colocal-Memphis, Tennessee 38105
ization suggest that the two genes resulted from a recent
gene duplication. Since both genes are expressed in a
variety of cell types, it was anticipated that they would
Summary be functionally redundant.
Stat5a and Stat5b proteins are activated by tyrosine
A variety of cytokines mediate the activation of Janus phosphorylation in response to a wide variety of cyto-
protein tyrosine kinases (Jaks). The Jaks then phos- kines. In addition to prolactin, Stat5 proteins are acti-
phorylate cellular substrates, including members of vated by growth hormone (GH) (Gouilleux et al., 1995;
the signal transducers and activators of transcription Wood et al., 1995), erythropoietin (Epo) (Quelle et al.,
(Stat) family of transcription factors. Among the Stats, 1996), thrombopoietin (Tpo) (Pallard et al., 1995), in-
the two highly related proteins, Stat5a and Stat5b, are terleukin 3 (IL-3) and GM-CSF (Mui et al., 1996), and
interleukin 2 (IL-2) (Hou et al., 1995; Wakao et al., 1995).activated by a variety of cytokines. To assess the role
In addition, the activation of the Stat5 proteins has beenof the Stat5 proteins, mutant mice were derived that
implicated in bcr/abl transformation (Ilaria and Van Et-have the genes deleted individually or together. The
ten, 1996; Shuai et al., 1996) and transformation of lym-phenotypes of the mice demonstrate an essential, and
phocytes to factor independence (Migone et al., 1995).often redundant, role for the two Stat5 proteins in a
The role of Stat5 activation in erythroid proliferationspectrum of physiological responses associated with
or differentiation has been examined by various ap-growth hormone and prolactin. Conversely, the re-
proaches. Receptor mutants have been used that aresponses to a variety of cytokines that activate the
unable to recruit the Stat5 proteins to the receptor com-Stat5 proteins, including erythropoietin, are largely un-
plex and thus fail to activate them. Our results (Quelleaffected.
et al., 1996) indicated that Stat5 activation was not re-
quired for Epo-induced proliferation, while other studies
Introduction (Damen et al., 1995; Gobert et al., 1996) concluded that
Stat5 activation was required. The effects of dominant-
Cytokines regulate theproliferation and/or differentiated negative forms of Stat5 have also been examined and
functions of cells through their interaction with receptors used to implicate the Stat5 proteins in erythroid differen-
of the cytokine receptor superfamily. These receptors tiation (Chretien et al., 1996; Iwatsuki et al., 1997; Wakao
mediate their diverse effects through their ability to as- et al., 1997) as well as a role in IL-3±induced proliferation
sociate with and activate members of the Janus family (Mui et al., 1996). However, in both cases, the effects
of protein tyrosine kinases (Jaks) (Darnell, Jr. et al., 1994; were partial and, consequently, not definitive in estab-
Ihle, 1995a, 1995b). Among the substrates of the Jaks are lishing a critical, nonredundant role. Similar types of
members of the signal transducers and activators of ambiguities exist in establishing a role for the Stat5 pro-
transcription (Stat) family of proteins (Ihle, 1996; Darnell, teins in responses to other cytokines.
1997). The Stats are recruited to the receptor complexes To assess the role of the Stat5 proteins, we derived
through SH2 domain recognition of specific sites of re- mice in which the two genes are individually and simulta-
ceptor tyrosine phosphorylation, are phosphorylated by neously mutated. Because of the identity of the two
the Jaks, undergo dimerization, translocate to the nu- proteins, it was assumed they would be redundant in
cleus, and affect the expression of a wide range of function. Indeed, it was quite unexpected to find pheno-
types associated with the disruption of the individualgenes.
genes as recently reported for Stat5a (Liu et al., 1997)Seven mammalian Stat family members have been
and, independently, for Stat5b (Udy et al., 1997). Ouridentified, many of which play highly specific roles in
results support these findings but also demonstrate the
loss of additional functions associated with growth hor-
mone or prolactin. In addition, rather remarkably, the8 To whom correspondence should be addressed.
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Figure 1. Generation of Stat5a2/2, Stat5b2/2,
and Stat5a2/25b2/2 Mice
(A) Structure of the 59-end of the Stat5a locus,
Stat5a-hygro targeting vector, and predicted
Stat5a mutated locus.
(B) Structure of the59-end of the Stat5b locus,
Stat5b-neo targeting vector, and predicted
Stat5b mutated locus. Filled boxes indicate
exons. The locations of the 59 and 39 external
probes and PCR primers for genotyping are
indicated. ATG denotes the first coding exon.
Restriction enzyme sites shown are as fol-
lows: E, EcoRI; H, HindIII; K, KpnI; B, BamHI;
Xh, XhoI; Xb, XbaI; Ap, ApaI.
(C) Southern blot analysis of HindIII-digested
tail DNA Stat5a heterozygous F1 mice probed
with a 59 Kpn probe. The positions of the mu-
tant 7.8 kb and wild-type 6.6 kb HindIII frag-
ments are indicated. Mice homozygous (lane
1) and heterozygous (lanes 2 and 3) for the
Stat5a mutation, and a wild-type mouse (lane
4) are shown.
(D) Southern blot analysis of XbaI-digested
tail DNA from Stat5b heterozygous F1 mice
probed with a 39 EcoRI/KpnI probe. The posi-
tions of the mutant 25 kb and wild-type 9.5
kb XbaI fragments are indicated. Mice homo-
zygous (lane 2) and heterozygous (lane 1) for
the Stat5b mutation andwild-type mice (lanes
3 and 4) are shown.
(E) Southern blot analysis of XbaI-digested
(upper panel) and HindIII-digested (lower
panel) tail DNA from Stat5a/b heterozygous
F1 mice. Size of fragments and probes used
are the same as in (C) and (D). Mice doubly
homozygous (lanes 3 and 4) and doubly het-
erozygous (lane 2) for the Stat5a/b mutation
and a wild-type mouse (lane 1) are shown.
(F) Immunoprecipitation (IP) and Western blot
analysis of Stat5a, Stat5b, Stat3, and Stat1
protein expression in liver extracts from
Stat5a1/15b1/1, Stat5a2/25b1/1, Stat5a1/1
5b2/2, and Stat5a2/25b2/2 mice. Specific anti-
sera used for the IP and immunoblot (IB) of
the Stat proteins are indicated.
disruption of both genes failed to reveal a critical, nonre- Karyotypically normal, appropriately targeted ES cells
were injected into blastocysts of C57Bl/6 mice. Germlinedundant role in the response of a number of cytokines
that activate the Stat5 proteins. transmission was obtained for two Stat5a, three Stat5b,
and four Stat5a/b clones. Of the Stat5a/b germline ani-
mals, three were derived from clones in which targetingResults
had occurred on the same chromosome. No differences
in the phenotypes described below were observed amongDerivation and Initial Characterization
of Mutant Mice the independently derived mutant strains of mice.
Homozygously deleted animals were observed in theThe chromosomal colocalization of the two Stat5 genes
necessitated the disruption of both alleles in ES cells to offspring of all mutant strains (Figures 1C, 1D, and 1E) at
frequencies expected for normal Mendalian segregationobtain mice that lacked both proteins. For comparison,
mice lacking Stat5a or Stat5b alone were also gener- (data not shown). However, approximately one-third of
the Stat5a/b mutant mice die within 48 hr (data notated. The strategies used are illustrated in Figures 1A
and 1B. In both cases, targeting vectors were developed shown). A number of possible reasons for mortality were
examined, including altered blood glucose, triglycer-that delete the first coding exon and would generate
a protein null phenotype. A hygromycin B±containing cides, cholesterol, urea nitrogen, and lactate, without
identifying the basis for the mortality. In addition, thereconstruct was used to target the Stat5a gene, while a
neomycin containing construct was used to disrupt the was not an apparent neurological basis for the mortality,
since all the pups suckled and otherwise behaved nor-Stat5b locus. To generate the Stat5a1/25b1/2 ES cells,
Stat5a1/2 hygromycin-resistant ES cells were targeted mally.
The mutant strains were subsequently examined forin a second round with the Stat5b neomycin construct.
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Table 1. In Vitro Colony Formation Ability of Bone Marrow Hematopoietic Progenitors from Stat5 Wild-Type and Mutant Mice in
Response to Different Cytokines
Genotype
Colony Type Stat5a1/15b1/1 Stat5a2/25b1/1 Stat5a1/15b2/2 Stat5a2/25b2/2
Cytokine
Epo CFU-E 493 6 110 (n 5 16) 488 6 96 (n 5 4) 571 6 84 (n 5 6) 434 6 76 (n 5 7)
IL-3 1 Epo BFU-E 13 6 6 (n 5 16) 21 6 3 (n 5 4) 21 6 5 (n 5 6) 26 6 8 (n 5 7)
IL-3 CFU-Mix 319 6 65 (n 5 5) 302 6 8 (n 5 4) 310 6 24 (n 5 4) 182 6 63 (n 5 6)a
IL-5 CFU-Eos 12 6 4 (n 5 13) 10 6 3 (n 5 4) 18 6 4 (n 5 4) 3 6 2 (n 5 6)a
IL-7 Pre-B 41 6 2 (n 5 5) 38 6 3 (n 5 4) 38 6 2 (n 5 4) 11 6 5 (n 5 6)
Tpo CFU-Mk 8 6 5 (n 5 11) 9 6 2 (n 5 5) 4 6 2 (n 5 4) 4 6 2 (n 5 6)
G-CSF CFU-G 67 6 20 (n 5 14) 72 6 28 (n 5 4) 45 6 25 (n 5 5) 30 6 23 (n 5 6)
GM-CSF CFU-GM 378 6 91 (n 5 11) 422 6 68 (n 5 6) 555 6 113 (n 5 4) 176 6 42 (n 5 6)a
CSF-1 CFU-M 605 6 151 (n 5 4) 655 6 47 (n 5 4) 608 6 43 (n 5 4) 691 6 174 (n 5 4)
SCF CFU-Mix 48 6 8 (n 5 4) 42 6 2 (n 5 4) 41 6 4 (n 5 4) 35 6 9 (n 5 4)
Mean 6 standard deviation of number of colonies/105 nucleated bone marrow cells.
a Size of colonies reduced compared to wild-type.
the presence of Stat5 proteins by immunoprecipitation We also examined bone marrow hematopoietic pro-
genitors in colony assays (Table 1). Consistent with theand Western blotting of liver extracts. Carboxyl-termi-
nal, Stat5a-, or Stat5b-specific antisera were used to above, there was no detectable alteration in the number
of erythroid colony-forming cells (CFU-E) in any of theallow the detection of amino-terminal truncated pro-
teins. As illustrated in Figure 1F, Stat5a or Stat5a/b mu- mutant mice. However, there was a detectable reduction
in the number of colonies induced in response to IL-3tant mice lacked detectable Stat5a protein, and Stat5b
or Stat5a/b mutant mice lacked detectable Stat5b. (57% of wild type), IL-5 (25% of wild type), or GM-CSF
(47% of wild type), and the size of the colonies wasMoreover, the disruption of one Stat5 gene did not affect
the expression of the remaining gene. Although not evi- detectably smaller. The response of bone marrow cells
to G-CSF±induced colony formation was also reduceddent in the data presented, we have detected truncated
Stat5a and Stat5b proteins on overexposed blots that to a comparable extent. Since G-CSF primarily induces
Stat3 activation (Tian et al., 1994; Tweardy et al., 1995),are estimated tooccur at 1% or less of the normal levels.
Since the Stat3 gene is approximately 5 kb from the it is possible that the reduction in colonies is secondary
to other effects. Lastly, there were no detectable alter-Stat5a gene, oriented in a tail-to-tail configuration (un-
published data), we examined the effects of the gene ations in the responses to colony-stimulating factor 1
(CSF-1) or stem cell factor (SCF), two cytokines thatdisruptions on Stat3 levels. As illustrated in Figure 1F,
Stat5a mutant mice and the Stat5a/b mutant mice had utilize tyrosine kinase receptors.
IL-7 also activates Stat5 and is critical for early lymphoidsomewhat lower levels of Stat3.The complete disruption
of Stat3 results in an early embryonic lethality (Takeda expansion. In none of the mutant mice was there a de-
tectable decrease in thymocytes or peripheralB cells (dataet al., 1997), indicating that the decrease is unlikely to
be significant. Lastly, there was a small increase in the not shown). However, as indicated in Table 1, the num-
ber of IL-7±induced bone marrow colonies in Stat5a/bStat1 levels that was comparable to those previously
observed in the Stat5b-deficient mice (Udy et al., 1997). mutant mice was 27% of control and has varied in vari-
ous experiments from this value to approximately 40%
of control. However, the number of pre±B cells (B2201,Effects of Stat5 Gene Disruptions on Hematopoiesis
The activation of the Stat5 proteins by Epo, Tpo, and CD432,IgM2) and B cells (B2201,CD432,IgM1), as as-
sessed by FACS analysis, was reduced by 64% andother hematopoietic cytokines prompted us to analyze
in some detail the hematopoietic functions in the mutant 36%, respectively. Since the Stat5a/b mice have a pro-
found deficiency in peripheral T cell proliferation (unpub-mice. There were no significant differences in several
parameters, including the number of red cells, hemoglo- lished data), it is possible that the reductions may be
secondary to these defects.bin levels, or the hemocrits among the wild-type mice
and the Stat5 mutant mice (data not shown). Similarly,
there were no significant differences in the numbers of Disruption of Stat5a or Stat5b Differentially
Affect Mammary Gland Developmentplatelets between wild type mice and the various mutant
mice. Lastly, in the Stat5a/b mutant mice, but not in Whole mammary gland mounts and histological sec-
tions are illustrated in Figure 2 for mature virgin mice ofStat5a or Stat5b mutant mice, there was a decrease in
the white cell count that was associated with a decrease all mutant strains and for the lactating Stat5a and Stat5b
mutant mice. As indicated below, female Stat5a/b micein the percentage of lymphocytes. Conversely, there
was an increased percentage of neutrophiles. The basis are infertile and therefore could not be examined. As
illustrated, the differentiation of ductal elements occursof the lymphocytopenia is considered below. Thus, in
terms of peripheral myelopoiesis, the various Stat5 mu- in all the mutant mice comparable to wild-type mice.
The major difference is the extent of development oftant mice have normal levels of erythrocytes, platelets,
neutrophiles, and monocytes. terminal buds in all mutant mice. Following pregnancy,
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Figure 2. Histology of Mammary Glands from Stat5 Female Mutant Mice
(A, B, C, and D) Wild-type. (E, F, G, and H) Stat5a2/2. (I, J, K, and L) Stat5b2/2. (M and N) Stat5a2/25b2/2. Mature virgin female mice are 12±14
weeks of age, and postpartum denotes 12 hr after delivery by 8- to 12-week-old female. (A, C, E, G, I, K, and M) Mammary gland whole
mounts stained with carmine. Bar, 1 mm. (B, D, F, H, J, L, and N) 4 mm sections stained with hematoxylin-eosin. Bar, 100 mm.
in response to prolactin, the alveolar development of demonstrate that both Stat5a and Stat5b contribute to
a-lactalbumin and WAP expression, redundantly. How-the mammarygland isgreatly amplified inwild-type mice
(Figures 2C and 2D). This expansion occurs relatively ever, neither plays a major role in b-casein expression.
normally in Stat5b mice (Figures 2K and 2L) but is dra-
matically reduced in Stat5a mice (Figures 2G and 2H). Stat5a/b Mutants Have Altered Ovarian
Development and Are InfertileThe development of the mammary gland is dependent
upon the level of prolactin signaling, as indicated by the As noted above, the Stat5a/b mutant female mice, but
not the Stat5a or Stat5b mutants, were infertile. Thelack of lactation when a single prolactin receptor allele
is disrupted (Ormandy et al., 1997). Thus, the differential basis for the infertilitywas readilyevident from thehistol-
ogy of the ovaries (Figures 4A and 4B). In both wild-effects of Stat5a and Stat5b deletion could be due to
protein levels or extent of activation. Tyrosine phosphor- type and mutant mice, developing follicles were evident,
including mature Graafian follicles. Examination of theylation of both Stat5a and Stat5b is detected in wild-
type animals at 12 or 36 hr postpartum (Figure 3). Using oviducts of Stat5a/b mutant mice also indicated that
ovulation can occur normally (data not shown). How-an excess of anti-Stat antibodies, there was a reproduci-
bly 3- to 5-fold lower level of tyrosine phoshorylated ever, whereas ovaries from wild-type mice invariably
had large corpora lutea, there were either few or noStat5b, and the levels of Stat5b protein were approxi-
mately 2- to 3-fold lower. These levels were not altered large corpora lutea evident in the Stat5a/b mutant mice.
To further relate Stat5 function to ovarian develop-in the mutant mice. These data suggest that the pheno-
typic differences are related to thehigher levelof expres- ment, we identified the siteswithin the ovary where Stat5
activation was occurring by taking advantage of the ob-sion of Stat5a rather than a isotype-specific function.
We also examined the levels of milk protein produc- servation that Stat5 induces the gene ªcytokine-induc-
ible SH2-containing proteinº (CIS) (Yoshimura et al.,tion (Figure 3B). The absence of either Stat5a or Stat5b
resulted in a significant decrease in a-lactalbumin rela- 1996). By in situ hybridization (Figure 4C), the major
site of expression is in the corpora lutea and not intive to wild-type mice, both at 12 and 36 hr of lactation,
despite the differences in the gross mammary gland developing or mature follicles. Consistent with a role for
the Stat5 proteins, no CIS expression was detected indevelopment. A comparable pattern was seen in the
expression of WAP (whey acidic protein), although, with any structures in the ovaries of Stat5a/b mutant mice
(Figure 4D). In the presence of prolactin, follicle granu-the mammary gland development that occurs in the
Stat5b mutants, the levels of WAP increased to normal losa cells develop into a functional corpus luteum. In
the absence of sufficient prolactin, the granulosa cellslevels. In contrast, there was a much less dramatic effect
of mutation of Stat5a or Stat5b on b-casein. The results differentiate to copora lutea atretica. Functional corpora
Stat5 Proteins Mediate GH and Pro Functions
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Figure 3. Mammary Gland Expression of Stat5a, Stat5b, and Milk
Protein Genes in Stat5 Mutant Mice
(A) Western blot analysis of mammary gland extracts from wild-
type, Stat5a2/2, and Stat5b2/2 mice at 12 and 36 hr postpartum
immunoprecipitated (IP) with antisera specific for Stat5a and Stat5b,
and immunoblotted (IB) with anti-phosphotyrosine sera (top panel).
The blot was stripped and reprobed with the Stat5a- and Stat5b-
specific antisera (bottom panel).
(B) Northern blot analysis of total RNA (15 mg/lane) from wild-type,
Stat5a2/2, and Stat5b2/2 mice at 12 and 36 hr postpartum. Milk
protein gene expression were assessed by successive hybridization
with oligonucleotide probes for a-lactalbumin, b-casein, and whey
acidic protein (WAP). Reprobing with GAPDH cDNA probe served
as control for loading.
Figure 4. Histology and In Situ Hybridization of Wild-Type and
Stat5a2/25b2/2 Ovaries
lutea synthesize progesterone, while copora lutea atret- (A, C, and E) Wild-type and (B, D, and F) Stat5a2/25b2/2 ovaries
from 8-week-old female mice. (A and B) Hematoxylin-eosin±stainedica express the enzyme 20-a-hydroxysteriod dehydro-
6 mm sections. (C and D) Dark-field image of in situ hybridizationgenase (20aSDH), which converts progesterone to an
with Cis cRNA probe (6 mm sections). (E and F) Bright-field image ofinactive derivative. Suppression of 20aSDH expression
in situ hybridization with 20a-hydroxysteroid dehydrogenase cRNA
has been proposed to be due to prolactin signaling probe (6 mm sections). (G andH) Dark-field imageof in situhybridiza-
(Zhong et al., 1997). By in situ hybridization (Figure 4E), tion with Cyclin D2 cRNA probe. (I and J) Dark-field image of in situ
20aSDH was not expressed in the corpora lutea or folli- hybridization with p27 cRNA probe.
cles but rather in the copora lutea atretica. In the Stat5a/b
mutant mice, the 20aSDH-expressing structures were
much more prevalent. The results suggest that Stat5 expression was detected only in the granulosa cells of
developing follicles, and this expression was not alteredmediates a prolactin-induced signal that is critical for
the differentiation of functional copora lutea and/or in Stat5a/b mutant mice. In contrast, p27 is highly ex-
pressed in corpora lutea of wild-type mice. Moreover,suppression of differentiation to copora lutea atretica.
Alternatively, the Stat5 proteins may directly suppress p27 expression was not detectable in any of the struc-
tures of the ovaries of Stat5a/b-deficient mice, sug-20aSDH expression, and the attendant changes in pro-
gesterone concentrations may affect differentiation. gesting a role for the Stat5 proteins in p27 expression
but not cyclin D2.Recently, cyclin D2 and p27 have been shown to be
required for ovarian function by gene disruptions (Fero
et al., 1996; Kiyokawa et al., 1996; Nakayama et al., Stat5a and Stat5b Are Essential for Growth
Hormone Functions1996; Sicinski et al., 1996). To assess the relationship
of these gene products to Stat5, we used in situ hybrid- The potential roles of the Stat5 proteins in mediating
growth hormone effects were readily evident from theization to examine cyclin D2 and p27 expression in wild-
type and mutant mice (Figures 4G and 4H). Cyclin D2 size of the mice (Figure 5). The most dramatic phenotype
Cell
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Figure 5. Body Growth Ratesof Stat5 Mutant
Mice
(A) Representative male littermates; wild-type
(bottom) andStat5a2/25b2/2 (top) at 14weeks
of age.
(B) Growth curves of wild-type, Stat5a2/2,
Stat5b2/2, and Stat5a2/25b2/2 male mice
from 1 through 12 weeks of age.
(C) Representative female littermates; wild-
type (bottom) and Stat5a2/25b2/2 (top) at 8
weeks of age.
(D) Growth curves of wild-type, Stat5a2/2,
Stat5b2/2, and Stat5a2/25b2/2 female mice
from 1 through 12 weeks of age.
was observed in Stat5a/b mutant mice. At 12 weeks of We also examined the expression of male predomi-
age, the male and female mice weighed 30%±40% and nant and male suppressed genes (Figure 6). The P450
20%±30% less than their wild-type littermates. No effect gene CYP2D9 is expressed at higher levels in male mice
was seen in the Stat5a mutant mice, while the Stat5b relative to females (please note that the CYP2D9 gene
male mice were consistently 20%±30% smaller than product is the protein that migrates slightly below the
their wild-type littermates. The Stat5a/b mutant pheno- upper protein). This expression is lost in the Stat5b and
types are quite similar to those observed in growth hor- the Stat5a/b mutant male mice and, to a lesser extent,
mone (Donahue and Beamer, 1993) or growth hormone in the Stat5a mutant male mice. Conversely, the P450
receptor±deficient mice (Zhou et al., 1997). The growth gene CYP2A4 is normally expressed at higher levels in
hormone receptor±deficient mice also display a de- females relative to males. As illustrated in Figure 6B,
crease in fat deposition early in life (unpublished data). the Stat5b mutant male mice have levels of CYP2A4
Consistent with this, Stat5a and Stat5b mutant mice had that are similar to the levels seen in female wild-type
somewhat reduced epidemal fat pads, while the fat pads and Stat5a/b mutant mice. A similar increase in CYP2A4
of Stat5a/b mutant mice were approximately one-fifth
that of wild type (data not shown).
Some of the effects of growth hormone are related to
induction of insulin-like growth factor 1 (IGF-1). As a
consequence, growth hormone receptor±deficient mice
have reduced serum IGF-1 (Zhou et al., 1997). IGF-1
levels were significantly reduced in Stat5a/b mutant
male relative to wild-type (173 6 23 vs. 340 6 6) and
female (127 6 53 vs. 284 6 40) mice. The levels of serum
IGF-1 were reduced in male Stat5b mutant mice (175 6
18) but not in the females, while the levels were normal
in both male and female Stat5a mutant mice. Growth
hormone has also been implicated in the regulation of
a number of liver genes that are expressed in a sexually
dimorphic pattern (Udy et al., 1997), and Stat5b has
been implicated in this expression. The pattern of the
major urinary protein (MUP) is illustrated in Figure 6A.
Female wild-type mice express approximately 3- to
5-fold lower levels of MUP than males. In males, the
Figure 6. Regulation of Hepatic Gene Expression by Stat5bdeletion of Stat5a alone or Stat5b alone resulted in no
(A) Urine (1 ml) from Stat5a, Stat5b, and Stat5a/b (1/1) and (2/2)changes in MUP levels. However, the deletion of both
male and female mice resolved by SDS polyacrylamide gel electro-genes resulted in a dramatic reduction in MUP levels in
phoresis and stained with Coomassie blue.males. In females, the deletion of Stat5a alone had no
(B) Immunoblot analysis of liver microsomes (10 mg) from Stat5a,
effect on MUP levels, while the deletion of Stat5b re- Stat5b, and Stat5a/b (1/1) and (2/2) male and female mice with
sulted in a significant decreasein MUP expression. How- antibody to female predominant (male suppressed) testosterone
ever, the deletion of both Stat5a and Stat5b resulted in 15a-hydroxylase (CYP2A4) or to male predominant testosterone
16a-hydroxylase (CYP2D9).undecteable levels of MUP proteins in females.
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expression was not seen in the Stat5a mutant males. since D2 is not expressed where Stat5 activation occurs
and its expression requires a follicle stimulating hor-Similar results were obtained with several additional
male suppressed P450 genes, including CYP3A and mone (FSH)±dependent, cAMP pathway (Sicinski et al.,
1996). In contrast, p27 is expressed at high levels in theCYP4A (data not shown).
corpora lutea, and the disruption of the p27 gene results
in an ovarian defect that is similar to that observed in
Discussion the Stat5a/b-deficient mice (Fero et al., 1996; Kiyokawa
et al., 1996; Nakayama et al., 1996). It is tempting to
The results demonstrate that Stat5a and Stat5b are re- speculate that the Stat5 proteins regulate p27 expres-
quired, either individually or redundantly, in virtually all sion and that this expression is critical for inducing the
the physiological responses associated with either growth differentiation of granulosa cells along a pathway for
hormone or prolactin. Conversely, it is remarkable that the formation of functional corpora lutea.
the Stat5 transcription factors play either no role, or Previous studies (Zhong et al., 1997) suggested that
redundant roles, in the response of a number of related prolactin is required for thesuppression of 20aSDH gene
cytokines that activate their transcriptional function. expression. As demonstated here, 20aSDH is not ex-
Perhaps the most striking observation is the lack of pressed in the developing follicles or in the functional
any effect on Epo functions. There were no detectable corpora lutea but rather in corpora lutea atretica. In the
alterations in red cell production in vivo nor were there Stat5a/b mutant mice, there are many more 20aSDH
any detectable effects on Epo-induced colonies from expressing corpora lutea atretica. Thus, the Stat5 pro-
bone marrow cells. This is surprising, since numerous teins are either critical for inducing the formation of
studies have implicated Stat5 in proliferation and/or dif- functional corpus lutea and that, associated with this,
ferentiation (Damen et al., 1995; Gobert et al., 1995; Mui is the lack of induction of 20aSDH. Alternatively, activa-
et al., 1996; Ogawa et al., 1996; Iwatsuki et al., 1997; tion of the Stat5 proteins in the functional corpus lutea
Wakao et al., 1997; Woldman et al., 1997). However, may be responsible for the suppression of 20aSDH ex-
the effects were always partial, and therefore it may be pression.
necessary to study erythroid differentiationin the mutant The basis for the infertility of Stat5a/b mutant mice
mice in additional ways to detect subtle effects. can be attributed to the absence of sufficient progester-
The receptors for Epo and Tpo, as well as growth one to support implantation and subsequent placental
hormone and prolactin, are structurally similar and may development and maintanence. The importance of pro-
have been derived from a primordial receptor. Because gesterone in ovarian and uterine functions is evident
of this, it is more striking that, while growth hormone from the phenotype of progesterone receptor±deficienct
and prolactin require the Stat5 proteins, Epo and Tpo mice (Lydon et al., 1995). The primary site of production
do not. It is possible that throughevolution the receptors of progesterone during pregnancy is the corpora lutea
maintained, or acquired, the tyrosines critical for the of the ovary. The lack of development of corpora lutea
recruitment of the Stat5 proteins, although functionally, would therefore be expected to have a significant effect
the requirement for the Stat5 proteins was only retained, on the levels of progesterone. In addition, the accumula-
or acquired, in the responses to growth hormone or tion of corpora lutea altricans, which express high levels
prolactin. Alternatively, the responses to Epo or Tpo of 20aSDH, would further contribute to decreasing the
could have evolved backup, redundant signaling path- levels of progesterone.
ways to the Stat5 proteins. The phenotype of growth hormone receptor±deficient
There were detectable effects on some cytokine col- mice has recently been described (Zhou et al., 1997).
ony-forming responses of bone marrow cells from Some of the phenotypes are observed in Stat5b mutant
Stat5a/b mutant mice, including IL-3 and GM-CSF, and mice, while all the phenotypes areevident in theStat5a/b
thus the Stat5 proteins may contribute redundantly to mutant mice. Interestingly, the principle differences
these responses. A reduction in these activities would were in females with only a Stat5b mutation, which
not be anticipated to have a physiological consequence, showed normal IGF-1 levels and growth. These differ-
since mice lacking the ability to respond to IL-3, GM- ences may also be due to the differences of the Stat5a
CSF, as well as IL-5, have no hematopoietic phenotypes and Stat5b levels. Specifically, Stat5b is much more
(Nishinakamura et al., 1996). The possibility that the ef- highly expressed in the liver than Stat5a (Ripperger et
fects are not directly due to absence of Stat5 proteins al., 1995). In contrast Stat5a and Stat5b levels are com-
is suggested by decreased response to G-CSF, which parable in ovary (data not shown). In this context, the
predominantly activates Stat3. The possiblity exists that observation that the corpus luteum produces IGF-1
immune defects described below indirectly affect the (Parmer et al., 1991) helps to explain the sex differences
levels of bone marrow progenitor cells. in the phenotype. Thus, in males, the primary source of
The Stat5 proteins are essential for the development IGF-1 is the liver, while in females both liver and ovaries
of functional corpora lutea in theovary. This is consistent can contribute. The ovarian contribution is only elimi-
with the critical role that prolactin has in ovarian function nated by the absence of both Stat5a and Stat5b.
based on the female infertility of both prolactin-deficient The data suggest that most of the physiological re-
mice (Horseman et al., 1997) and prolactin receptor± sponses to growth hormone involve receptor activation
deficient mice (Ormandy et al., 1997). Female infertility of Stat5 proteins by Jak2. These observations are not
was not observed in the Stat5a or Stat5b mutant mice, consistent with recent experiments concerned with
demonstrating the functional redundancy of the Stat5 growth hormone±induced tyrosine phosphorylation of
proteins. The critical targets of this signaling pathway the epidermal growth factor (EGF) receptor (Yamauchi
et al., 1997). The authors concluded from their studiesare not known. A role in cyclin D2 regulation is unlikely,
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cytokines were mixed with MethoCult M3230 (StemCell Technolo-that growth hormone±induced tyrosine phosphorylation
gies) except for the pre±B cell assay (see below) giving a final con-of the EGF receptor and its ability to activate MAP ki-
centration of 0.9% methylcellulose. Assays were plated in 35 mmnases were critical to growth hormone function. From
culture dishes in duplicate and cultured at 378C. CFU-E assays
the phenotype of the Stat5a/b-deficient mice, it is not contained 5 3 104 cells/dish and 0.2 U/ml recombinant human eryth-
clear what growth hormone functions might be depen- ropoietin, rhEpo (Amgen). Benzidine-positive CFU-E colonies were
scored at day 3. BFU-E assays contained 2 3 105 cells/dish and 3dent upon other signaling pathways.
U/ml rhEpo and 10 ng/ml recombinant murine IL-3, rmIL-3 (R&DThe results described here have focused on the phe-
Systems). Benzidine-positive BFU-E colonies were scored at daynotypes observed in the mutant mice that are directly
8. CFU-Mix assays contained 1.5 3 104 cells/dish and 10 ng/mlattributable to deficiencies in growth hormone and pro-
rmIL-3 or 2 3 105 cells/dish and 50 ng/ml rmSCF (R&D Systems).
lactin function. In addition, however, the Stat5a/b mu- Colonies were scored at day 12. CFU-Meg assays contained 4 3
tant mice, but not the individual mutants, have a pro- 105 cells/dish and 50 ng/ml recombinant human thrombopoietin,
rhTpo (Genzyme). Colonies were scored at day 8. CFU-GM andfound defect affecting the T cell lineage (unpublished
CFU-M assays contained 1.5 3 104 cells/dish and 10 ng/ml rmGM-data). Specifically, peripheral T cells are unable to prolif-
CSF or 10 ng/ml rmCSF-1 (R&D Systems). Colonies were scored aterate in response to T cell receptor engagement and
day 12. CFU-G assays contained 5 3 104 cells/dish and 10 ng/IL-2, although IL-2 receptor expression is unaltered and
ml rhG-CSF (Amgen) and were scored at day 12. CFU-Eos assays
the T cells are able to produce cytokines. This aspect of contained 2 3 105 cells/dish and 20 ng/ml rmIL-5 (R&D Systems),
the defects of Stat5a/b mutantmice strikingly resembles and colonies were scored at day 18. Pre±B cell assays contained
5 3 104 cells/dish and were cultured in MethoCult M3630 (StemCellthat seen in IL-2 receptor b chain±deficient mice (Suzuki
Technologies) including 10 ng/ml rhIL-7 and colonies scored atet al., 1995). In summary, the phenotypes of the Stat5a/b
day 8.mice illustrate remarkably specific functions for the
Stat5 proteins in mediating virtually all growth hormone
Histology and In Situ Hybridizationand prolactin functions, but, in addition, one can hypoth-
Mammary glands for whole mounts were spread on glass slidesesize that during the evolution of T cell function the
andfixed 4 hr in Carnoy's fixative. The tissueslides were sequentiallyStat5 genes were incorporated into T cell regulation.
rehydrated 15 min each in a graded ethanol (70%, 50%, 30%, 10%,
and H2O) and stained overnight (0.2% w/v carmine [Sigma]/0.5%
Experimental Procedures w/v aluminum potassium sulfate [Sigma]). The slides were dehy-
drated 15 min each in 70%, 95%, and 100% ethanol (2 times) fol-
Stat5a and Stat5b Gene Disruptions lowed by clearing in Hemo-De (Fisher). For sectioning, tissues were
The Stat5a and Stat5b genes were isolated from a 129/SvE mouse fixed in 10% phosphate-buffered formalin (Fisher), paraffin embed-
genomic library in lEMBL3. For the Stat5a targeting vector, a 9.3 ded, sectioned at 4 mm (mammary glands) or 6 mm (ovaries), and
kb EcoRI/SalI fragment was subcloned, followed by replacement of stained in hematoxylin and eosin.
a 1.0 kb XhoI/HindIII fragment containing the two first Stat5a coding For in situ hybridization, ovaries were fixed by perfusion with 4%
exons with a hygromycin resistance cassette (van Deursen et al., paraformaldehyde (Sigma), and 6 mm sections were prepared from
1991). For the Stat5b targeting vector, a 1.6 kb NheI/ApaI fragment frozen tissue samples. In situ hybridization was carried out essen-
and a 6.3 kb XhoI/EcoRI fragment were subcloned 59 and 39, respec- tially as described (Angerer and Angerer, 1992) using [g-33P]UTP-
tively, of a neomycin resistance cassette from pMC1neo-polyA labeled antisense RNA probes transcribed from plasmids containing
(Stratagene), thereby leaving out the first Stat5b coding exon. A murine cDNA fragments of Cis (216 bp), 20a-hydroxysteroid dehy-
herpes simplex virus thymidine kinase (HSV-tk) cassette mediating drogenase (670 bp), Cyclin D2 (1.2 Kbp), and p27 (591 bp). Tissue
negative selection was inserted in the 59- and 39-end of the Stat5b- sections were counterstained using toluidine blue (Sigma).
neo and Stat5a-hygro construct, respectively.
E14 (129/Ola mouse strain) or RW4 (129/SvJ mouse strain [Ge-
Immunoprecipitation and Western Blot Analysisnome Systems]) embryonic stem (ES) cells were cultured as pre-
Total cell extracts were prepared from tissue homogenized in 10viously described (Parganas et al., 1998). To generate the Stat5a1/2
mM Tris-HCl (pH 7.6)/5 mM EDTA/50 mM NaCl/30 mM sodium pyro-5b1/2 ES clones, Stat5a1/2 hygroR ES cells were targeted a second
phosphate/50 mM sodium fluoride/1 mM sodium orthovanadate/time now with the Stat5b-neo construct and double-resistant clones
10% glycerol with Complete protease inhibitor cocktail (Boehringerselected. Conditions for blastocyst injection were essentially as de-
Mannheim). The methods used to detect Stat proteins have beenscribed (van Deursen et al., 1993). Ten, nine, and fifteen independent
described (Quelle et al., 1995; Wang et al., 1996). For analysis ofES clones were injected for Stat5a, Stat5b, and Stat5a/b, respec-
major urinary proteins (MUPs), 1 ml of mouse urine was resolved bytively, of which two, three, and four clones, respectively, gave germline
12% SDS-PAGE followed by Coomassie blue staining (Norstedttransmission. In three of the Stat5a1/25b1/2 ES clones, targeting
and Palmiter, 1984). For the P450 analysis, liver microsomes werehad occurred on the same chromosome as revealed by the F1
prepared and 10 mg analyzed on immunoblots using rabbit antibod-offspring genotypes. Tail DNA was prepared as described (Hogan
ies to either female predominant testosterone 15a-hydroxylaseet al., 1994). Genotyping of mice was performed by Southern blot
(CYP2A4) (Squires and Negishi, 1988) or male predominant testos-analysis or by PCR. For PCR, the primers consisted of Stat5a: F9
terone 16-hydroxylase (CYP2D9) generously provided by Dr. M.primer (59-AAGGGACAGGAAGAGAGAAGG-39), R1 primer (59-CCCA
Negishi (NIEHS, Research Triangle Park, NC), followed by HRP-TACAACACTTGCATCT-39); TK: TKp primer (59-GCAAAACCACAC
conjugated anti-rabbit IgG and ECL.TGCTCGAC-39); Stat5b: R8 primer (59-GGAGATCTGCTGGCTGA
AAG-39), F11 primer (59-TCAAACACACCTCAATTAGTC-39).
To detect Stat5a homologous targeting by Southern blotting, a
Acknowledgments
HindIII digest was probed with a 500 bp KpnI fragment giving a 6.6 kb
wild-type and a 7.8 kb mutant allele. To detect Stat5b homologous
The authors would like to thank Linda Snyder for her excellent tech-
targeting, a XbaI digest was probed with a 900 bp EcoRI/KpnI frag-
nicalassistance in conducting the studies. This work was supported,
ment giving a 9.5 kb wild-type and a 25 kb mutant allele.
in part, by Cancer Center CORE grant CA21765, by grant RO1
DK42932 to J. N. I., by grant PO1 HL53749 to J. N. I., by grant RO1
Bone Marrow Colony Assays ES08658 to E. S., and by the American Lebanese Syrian Associated
Bone marrow cells were prepared from femurs in a-MEM medium Charities (ALSAC).
(GIBCO-BRL) containing 2% fetal bovine serum (FBS) (StemCell
Technologies) and counted in the presence of 3% acetic acid to
lyse the erythrocytes. Diluted cell suspensions and recombinant Received March 20, 1998; April 21, 1998.
Stat5 Proteins Mediate GH and Pro Functions
849
References induce the tyrosine phosphorylation and DNA binding activity of
multiple specific STAT family members. J. Biol. Chem. 271, 31704±
31710.Angerer, L.M., and Angerer, R.C. (1992). In situ hybridization to cellu-
lar RNA with radiolabelled RNA probes. In In Situ Hybridization: A Iwatsuki, K., Endo, T., Misawa, H., Yokouchi, M., Matsumoto, A.,
Practical Approach, D.G. Wilkinson, ed. (Oxford: Oxford University Ohtsubo, M., Mori, K.J., and Yoshimura, A. (1997). STAT5 activation
Press), pp. 15±32. correlates with erythropoietin receptor-mediated erythroid differen-
tiation of an erythroleukemia cell line. J. Biol. Chem. 272, 8149±8152.Chretien, S., Varlet, P., Verdier, F., Gobert, S., Cartron, J.-P., Gissel-
brecht, S., Mayeux, P., and Lacombe, C. (1996). Erythropoietin- Kaplan, M.H., Schindler, U., Smiley, S.T., and Grusby, M.J. (1996a).
induced erythroid differentiation of the human erythroleukemia cell Stat6 is required for mediating responses to IL-4 and for thedevelop-
line TF-1 correlates with impaired stat5 activation. EMBO J. 15, ment of Th2 cells. Immunity 4, 313±319.
4174±4181. Kaplan, M.H., Sun, Y.-L., Hoey, T., and Grusby, M.J. (1996b). Im-
paired IL-12 responses and enhanced development of Th2 cells inCopeland, N.G., Gilbert, D.J., Schindler, C., Zhong, Z., Wen, Z.,
Stat4-deficient mice. Nature 382, 174±177.Darnell, J.E., Jr., Mui, A.-F., Miyajima, A., Quelle, F.W., Ihle, J.N.,
and Jenkins, N.A. (1995). Distribution of the mammalian Stat gene Kiyokawa, H., Kineman, R.D., Manova-Todorova, K.O., Soares, V.C.,
family in mouse chromosomes. Genomics 29, 225±228. Hoffman, E.S., Ono, M., Khanam, D., Hayday, A.C., Frohman, L.A.,
and Koff, A. (1996). Enhanced growth of mice lacking the cyclin-Damen, J.E., Wakao, H., Miyajima, A., Krosl, J., Humphries, R.K.,
dependent kinase inhibitor function of p27(Kip1). Cell 85, 721±732.Cutler, R.L., and Krystal, G. (1995). Tyrosine 343 in the erythropoietin
receptor positively regulates erythropoietin-induced cell prolifera- Liu, X., Robinson,G.W., Gouilleux, F., Groner, B., and Hennighausen,
tion and Stat5 activation. EMBO J. 14, 5557±5568. L. (1995). Cloning and expression of stat5 and an additional homo-
logue (stat5b) involved in prolactin signal transduction in mouseDarnell, J.E.J. (1997). STATs and gene regulation. Science 277,
mammary tissue. Proc. Natl. Acad. Sci. USA 92, 8831±8835.1630±1635.
Liu, X., Robinson, G.W., Wagner, K.U., Garrett, L., Wynshaw-Boris,Darnell, J.E., Jr., Kerr, I.M., and Stark, G.R. (1994). Jak-STAT path-
A., and Hennighausen, L. (1997). Stat5a is mandatory for adult mam-ways and transcriptional activation in response to IFNs and other
mary gland development and lactogenesis. Genes Dev. 11, 179±186.extracellular signaling proteins. Science 264, 1415±1421.
Lydon, J.P., DeMayo, F.J., Funk, C.R., Mani, S.K., Hughes, A.R.,Donahue, L.R., and Beamer, W.G. (1993). Growth hormone defi-
Montgomery, C.A.J., Shyamala, G., Conneely, O.M., and O'Malley,ciency in ªlittleº mice results in aberrant body composition, reduced
B.W. (1995). Mice lacking progesterone receptor exhibit pleiotropicinsulin-like growth factor-1 and insulin-like growth factor-binding
reproductive abnormalities. Genes Dev. 9, 2266±2278.protein-3 (IGFBP-3), but does not affect IGFBP-2, 21 or 24. J.
Endocrinol. 136, 91±104. Meraz, M.A., White, J.M., Sheehan, K.C.F., Bach, E.A., Rodig, S.J.,
Dighe, A.S., Kaplan, D.H., Riley, J.K., Greenlund, A.C., Campbell,Durbin, J.E., Hackenmiller, R., Simon, M.C., and Levy, D.E. (1996).
D., et al. (1996). Targeted disruption of the Stat1 gene in mice revealsTargeted disruption of the mouse Stat1 gene results in compromised
unexpected physiologic specificity in the JAK-STAT signaling path-innate immunity to viral disease. Cell 84, 443±450.
way. Cell 84, 431±442.Fero, M.L., Rivkin, M., Tasch, M., Porter, P., Carow, C.E., Firpo, E.,
Migone, T.-S., Lin, J.-X., Cereseto, A., Mulloy, J.C., O'Shea, J.J.,Polyak, K., Tsai, L.H., Broudy, V., Perlmutter, R.M., Kaushansky, K.,
Franchini, G., and Leonard, W.J. (1995). Constitutively activated Jak-and Roberts, J.M. (1996). A syndrome of multiorgan hyperplasia
STAT pathway in T cells transformed with HTLV-1. Science 269,with features of gigantism, tumorigenesis, and female sterility in
79±81.p27(Kip1)-deficient mice. Cell 85, 733±744.
Mui, A.-F., Wakao, H., Kinoshita, T., Kitamura, T., and Miyajima, A.Gobert, S., Porteu, F., Pallu, S., Muller, O., Sabbah, M., Dusanter-
(1996). Suppression of interleukin-3-induced gene expression by aFourt, I., Courtois, G., Lacombe, C., Gisselbrecht, S., and Mayeux,
C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J.P. (1995). Tyrosine phosphorylation of the erythropoietin receptor:
15, 2425±2433.role for differentiation and mitogenic signal transduction. Blood 86,
Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shis-598±606.
hido, N., Horii, I., and Loh, D.Y. (1996). Mice lacking p27(Kip1) displayGobert, S., Chretien, S., Gouilleux, F., Muller, O., Pallard, C., Du-
increased body size, multiple organ hyperplasia, retinal dysplasia,santer-Fourt, I., Groner, B., Lacombe, C., Gisselbrecht, S., and May-
and pituitary tumors. Cell 85, 707±720.eux,P. (1996). Identification of tyrosine residues within the intracellu-
Nishinakamura, R., Miyajima, A., Mee, P.J., Tybulewicz, V.L.J., andlar domain of the erythropoietin receptor crucial for STAT5
Murray, R. (1996). Hematopoiesis in mice lacking the entire granulo-activation. EMBO J. 15, 2434±2441.
cyte-macrophage colony-stimulating factor/interleukin-3/interleu-Gouilleux, F., Pallard, C., Dusanter-Fourt, I., Wakao, H., Haldosen,
kin-5 functions. Blood 88, 2458±2464.L.A., Norstedt, G., Levy, D., and Groner, B. (1995). Prolactin, growth
Norstedt, G., and Palmiter, R. (1984). Secretory rhythm of growthhormone, erythropoietin and granulocyte-macrophage colony stim-
hormone regulates sexual differentiation of mouse liver. Cell 36,ulating factor induce MGF-Stat5 DNA binding activity. EMBO J. 14,
805±812.2005±2013.
Ogawa, S., Kurokawa, M.A.T.T., Mitani, K.K.K., Inazawa, J., Han-Hogan, B., Beddington, R., Costantini, F., and Lacy, E. (1994). Manip-
gaishi, A., Tanaka, K., Matsuo, Y., Minowada, J., Tsubota, T., Yazaki,ulating the Mouse Embryo: A Laboratory Manual, Second Edition
Y., and Hirai, H. (1996). Structurally altered Evi-1 protein generated(Cold Spring Harbor, New York: Cold Spring Harbor Laboratory
in the 3q21q26 syndrome. Oncogene 13, 183±191.Press).
Ormandy, C.J., Camus, A., Barra, J., Damotte, D., Lucas, B., Buteau,Horseman, N.D., Zhao, W., Montecino-Rodriguez, E., Tanaka, M.,
H., Edery, M., Brousse, N., Babinet, C., Binart, N., and Kelly, P.A.Nakashima, K., Engle, S.J., Smith, F., Markoff, E., and Dorshkind,
(1997). Null mutation of the prolactin receptor gene produces multi-K. (1997). Defective mammopoiesis, but normal hematopoiesis, in
ple reproductive defects in the mouse. Genes Dev. 11, 167±178.mice with a targeted disruption of the prolactin gene. EMBO. J. 16,
Pallard, C., Gouilleux, F., Benit, L., Cocault, L., Souyri, M., Levy, D.,6926±6935.
Groner, B., Gisselbrecht, S., and Dusanter-Fourt, I. (1995). Thromo-Hou, J., Schindler, U., Henzel, W.J., Wong, S.C., and McKnight,
poietin activates a STAT5-like factor in hematopoietic cells. EMBOS.L. (1995). Identification and purification of human Stat proteins
J. 14, 2847±2856.activated in response to interleukin-2. Immunity 2, 321±329.
Parganas, E.,Wang, D., Stravopodis, D., Topham, D.J.,Marine, J.-C.,Ihle, J.N. (1995a). Cytokine receptor signalling. Nature 377, 591±594.
Teglund, S., Vanin, E.F., Bodner, S., Colamonici, O.R., van Deursen,
Ihle, J.N. (1995b). The Janus protein tyrosine kinase family and its J. M., Grosveld, G., and Ihle, J.N. (1998). Jak2 is essential for signal-
role in cytokine signaling. Adv. Immunol. 60, 1±35. ing through a variety of cytokine receptors. Cell 93, 385±395.
Ihle, J.N. (1996). STATs: signal tranducers and activators of tran- Parmer, T.G., Roberts, C.T.J., LeRoith, D., Adashi, E.Y., Khan, I.,
scription. Cell 84, 331±334. Solan, N., Nelson, S., Zilberstein, M., and Gibori, G. (1991). Expres-
sion, action, and steroidal regulation of insulin-like growth factor-IIlaria, R.L.J., and Van Etten, R.A. (1996). P210 and P190(BCR/ABL)
Cell
850
(IGF-I) and IGF-I receptor in the rat corpus luteum: their differential (1995). Interleukin 2 and erthropoietin activate STAT5/MGF via dis-
tinct pathways. EMBO J. 14, 2527±2535.role in the two cell populations forming the corpus luteum. Endocri-
nology 129, 2924±2932. Wakao, H., Chida, D., Damen, J.E., Krystal, G., and Miyajima, A.
(1997). A possible involvement of Stat5 in erythropoietin-inducedQuelle, F.W., Shimoda, K., Thierfelder, W., Fischer, C., Kim, A., Ru-
ben, S.M., Cleveland, J.L., Pierce, J.H., Keegan, A.D., Nelms, K., hemoglobin synthesis. Biochem. Biophys. Res. Commun. 234,
198±205.Paul, W.E., and Ihle, J.N. (1995). Cloning of murine Stat6 and human
Stat6, stat proteins that are tyrosine phosphorylated in responses Wang, D., Stravopodis, D., Teglund, S., Kitazawa, J., and Ihle, J.N.
to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. (1996). Naturally occurring dominant negative variants of Stat5. Mol.
15, 3336±3343. Cell. Biol. 16, 6141±6148.
Quelle, F.W., Wang, D., Nosaka, T., Thierfelder, W.E., Stravopodis, Woldman, I., Mellitzer, G., Kieslinger, M., Buchhart, D., Meinke, A.,
D., Weinstein, Y., and Ihle, J.N. (1996). Erythropoietin induces activa- Beug, H., and Decker, T. (1997). STAT5 involvement in the differenti-
tion of Stat5 through association with specific tyrosines on the re- ation response of primary chicken myeloid progenitor cells to
ceptor that are not required for a mitogenic response. Mol. Cell. chicken myelomonocytic growth factor. J. Immunol. 159, 877±886.
Biol. 16, 1622±1631. Wood, T.J., Sliva, D., Lobie, P.E., Pircher, T.J., Gouilleux, F., Wakao,
Ripperger, J.A., Fritz, S., Richter, K., Hocke, G.M., Lottspeich, F., H., Gustafsson, J.A., Groner, B., Norstedt, G., and Haldosen, L.A.
and Fey, G.H. (1995). Transcription factors Stat3 and Stat5b are (1995). Mediation of growth hormone-dependent transcriptional ac-
present in rat liver nuclei late in an acute phase response and bind tivation by mammary gland factor/Stat 5. J. Biol. Chem. 270, 9448±
interleukin-6 response elements. J. Biol. Chem. 270, 29998±30006. 9453.
Shimoda, K., van Deursen, J., Sangster, M.Y., Sarawar, S.R., Carson, Yamauchi, T., Ueki, K., Tobe, K., Tamemoto, H., Sekine, N., Wada,
R.T., Tripp, R.A., Chu, C., Quelle, F.W., Nosaka, T., Vignali, D.A.A., M., Honjo, M., Takahashi, M., Takahashi, T., Hirai, H., et al. (1997).
et al. (1996). Lack of IL-4-induced Th2 response and IgE class Tyrosine phosphorylation of the EGF receptor by the kinase Jak2
switching in mice with disrupted Stat6 gene. Nature 380, 630±633. is induced by growth hormone. Nature 390, 91±96.
Shuai, K., Halpern, J., ten Hoeve, J., Rao, X., and Sawyers, C.L. Yoshimura, A., Ichihara, M.,Kinjyo, I., Moriyama, M., Copeland, N.G.,
(1996). Constitutive activation of STAT5 by the BCR-ABL oncogene Gilbert, D.J., Jenkins, N.A., Hara, T., and Miyajima, A. (1996). Mouse
in chronic myelogenous leukemia. Oncogene 13, 247±254. oncostatin M: an immediate early gene induced by multiple cyto-
kines through the JAK-STAT5 pathway. EMBO J. 15, 1055±1063.Sicinski, P., Donaher, J.L., Geng, Y., Parker, S.B., Gardner, H., Park,
M.Y., Robker, R.L., Richards, J.S., McGinnis, L.K., Biggers, J.D., et Zhong, L., Parmer, T.G., Robertson, M.C., and Gibori, G. (1997).
al. (1996). Cyclin D2 is an FSH-responsive gene involved in gonadal Prolactin-mediated inhibition of 20alpha-hydroxysteroid dehydro-
cell proliferation and oncogenesis. Nature 384, 470±474. genase gene expression and the tyrosine kinase system. Biochem.
Biophys. Res. Commun. 235, 587±592.Squires, E.J., and Negishi, M. (1988). Reciprocal regulation of sex-
dependent expression of testosterone 15 alpha-hydroxylase Zhou, Y., Xu, B.C., Maheshwari, H.G., He. L., Reed. M., Lozykowski,
(P-450(15 alpha)) in liver and kidney of male mice by androgen: M., Okada, S., Cataldo, L., Coschigamo, K., Wagner, T.E., Baumann,
evidence for a single gene. J. Biol. Chem. 263, 4166±4171. G., and Kopchick, J.J. (1997). A mammalian model for Laron syn-
Suzuki, H., Kundig, T.M., Furlonger, C., Wakeham, A., Timms, E., drome produced by targeted disruption of the mouse growth hor-
Matsuyama, T., Schmits, R., Simard, J.J.L., Ohashi, P.S., Griesser, mone receptor/binding protein gene (the Laron mouse). Proc. Natl.
H., Taniguchi, T., Paige, C.J., and Mak, T.W. (1995). Deregulated T Acad. Sci. USA 94, 13215±13220.
cell activation and autoimmunity in mice lacking interleukin-2 recep-
tor b. Science 268, 1472±1476.
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yo-
shida, N., Kishimoto, T., and Akira, S. (1997). Targeted disruption of
the mouse stat3 gene leads to early embryonic lethality. Proc. Natl.
Acad. Sci. USA 94, 3801±3804.
Thierfelder, W.E., van Deursen, J., Yamamoto, K., Tripp, R.A., Sara-
war, S.R., Carson, R.T., Sangster, M.Y., Vignali, D.A.A., Doherty,
P.C., Grosveld, G., and Ihle, J.N. (1996). Stat4 is required for IL-12
mediated responses of NK and T-cells. Nature 382, 171±174.
Tian, S.-S., Lamb, P., Seidel, H.M., Stein, R.B., and Rosen, J. (1994).
Rapid activation of the Stat3 transcription factor by granulocyte
colony-stimulating factor. Blood 84, 1760±1764.
Tweardy, D.J., Wright,T.M., Ziegler, S.F., Baumann, H., Chakraborty,
A., White, S.M., Dyer, K.F., and Rubin, K.A. (1995). Granulocyte
colony-stimulating factor rapidly activates a distinct STAT-like pro-
tein in normal myeloid cells. Blood 86, 4409±4416.
Udy, G.B., Snell, R.G., Wilkins, R.J., Park, S.-H., Ram, P.A., Waxman,
D.J., and Davey, H.W. (1997). Requirement of STAT5b for sexual
dimorphism of body growth rates and liver gene expression. Proc.
Natl. Acad. Sci. USA 94, 7239±7244.
van Deursen, J., Lovell-Badge, R., Oerlemans, F., Schepens, J., and
Wieringa, B. (1991). Modulation of gene activity by consecutive gene
targeting of one creatine kinase M allele in mouse embryonic stem
cells. Nucleic Acids Res. 19, 2637±2643.
van Deursen, J., Heerschap, A., Oerlemans, F., Ruitenbeek, W., Jap,
P., ter Laak, H., and Wieringa, B. (1993). Skeletal muscles of mice
deficient in muscle creatine kinase lack burst activity. Cell 74,
621±631.
Wakao, H., Gouilleux, F., and Groner, B. (1994). Mammary gland
factor (MGF) is a novel member of the cytokine regulated transcrip-
tion factor gene family and confers the prolactin response. EMBO
J. 13, 2182±2191.
Wakao, H., Harada, N., Kitamura, T., Mui, A.L.F., and Miyajima, A.
